These results suggest that ponatinib alone can effectively inhibit tumor growth by blocking the activation of PI3K/AKT/mTOR and JAK/STAT3 pathways in an orthotopic xenograft NB mouse model. The gene discussed is AKT1; the disease is neuroblastoma.